ArticleAmerican journal of leukemia research2020

High dose cytarabine, mitoxantrone, pegasapargase (HAM-pegA) in combination with dasatinib for the first-line treatment of Philadelphia chromosome positive mixed phenotype acute leukemia.

Ciera L Patzke et al.PubMed ↗Full text ↗

No numbers read from the abstract.